Neovascular Age-Related Macular Degeneration Treatment Market

The Growing Market of Neovascular Age-Related Macular Degeneration Treatment: A Comprehensive Overview 2032

The neovascular age-related macular degeneration (AMD) treatment market has experienced significant growth in recent years, driven by advancements in treatment technologies and an increasing prevalence of the condition. Valued at USD 11 billion in 2023 across seven major markets, this sector is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to …

The Growing Market of Neovascular Age-Related Macular Degeneration Treatment: A Comprehensive Overview 2032 Read More »